Orthofix International | OFIX - Sales Revenues

Stock Price
12.85
Daily Change
0.13 1.02%
Monthly
8.26%
Yearly
-0.85%
Q2 Forecast
12.04

Orthofix International reported $219.91M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 79.43M 3.72M Sep/2025
Artivion USD 115.99M 2.6M Dec/2025
AtriCure USD 140.5M 6.2M Dec/2025
Dexcom USD 1.26B 50M Dec/2025
EDAP TMS EUR 13.88M 2.16M Sep/2025
Globus Medical USD 826.4M 57.4M Dec/2025
Inogen USD 74.93M 504K Sep/2024
Insulet USD 783.8M 77.5M Dec/2025
Integra LifeSciences USD 434.9M 32.84M Dec/2025
J&J USD 24.1B 500M Mar/2026
Medtronic USD 9B 39M Jan/2026
Mesa Laboratories USD 62.84M 5.01M Dec/2024
Orthofix International USD 219.91M 14.28M Dec/2025
Plus Therapeutics USD 1.37M 30K Dec/2025
Smith & Nephew USD 3.18B 353M Dec/2025
STAAR Surgical USD 239.4M 144.7M Dec/2025
Stryker USD 7.2B 1.14B Dec/2025
Surmodics USD 29.57M 355K Jun/2025
Tandem Diabetes Care USD 290.4M 41.15M Dec/2025
Teleflex USD 568.98M 344.02M Dec/2025
Veracyte USD 140.6M 8.7M Dec/2025
Zimmer Biomet Holdings USD 2.24B 240M Dec/2025